Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hawkins

Showing results (191-200 of 580) with videos related to

Pageof 58
Sort By:
Haematologica|May 25, 2011
Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosisAshutosh D Wechalekar, Julian D Gillmore, Nancy Wassef, et al.
QJM : Monthly Journal of the Association of Physicians|September 8, 2006
Renal amyloidosis in intravenous drug usersJ O Connolly, J D Gillmore, H J Lachmann, et al.
Journal of Cardiovascular Computed Tomography|September 28, 2016
Cardiac computed tomography for the detection of cardiac amyloidosisStefania Rosmini, Thomas A Treibel, Steve Bandula, et al.
Arthritis and Rheumatism|October 3, 2000
An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1qM F McDermott, E Aganna, G A Hitman, et al.
Human Mutation|November 3, 2000
Transthyretin Ile84Thr is associated with familial amyloid polyneuropathyD R Booth, A Stangou, R S Williams, et al.
BMJ Open|January 24, 2015
The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling studyM Guzman-Castillo, R Ahmed, N Hawkins, et al.
The American Journal of Cardiology|November 14, 1997
Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearanceG J Clesham, D M Vigushin, P N Hawkins, et al.
Clinical Cardiology|October 4, 2000
Tissue Doppler features of cardiac amyloidosisP M Elliott, N G Mahon, Y Matsumura, et al.
Biochemical and Biophysical Research Communications|June 15, 1994
Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's diseaseP N Hawkins, M N Rossor, J R Gallimore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 10, 2004
Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish familiesElizabeth B Haagsma, Philip N Hawkins, Merrill D Benson, et al.
Pageof 58

Showing results (191-200 of 580) with videos related to

Sort By:
Pageof 58
Haematologica|May 25, 2011
Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosisAshutosh D Wechalekar, Julian D Gillmore, Nancy Wassef, et al.
QJM : Monthly Journal of the Association of Physicians|September 8, 2006
Renal amyloidosis in intravenous drug usersJ O Connolly, J D Gillmore, H J Lachmann, et al.
Journal of Cardiovascular Computed Tomography|September 28, 2016
Cardiac computed tomography for the detection of cardiac amyloidosisStefania Rosmini, Thomas A Treibel, Steve Bandula, et al.
Arthritis and Rheumatism|October 3, 2000
An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1qM F McDermott, E Aganna, G A Hitman, et al.
Human Mutation|November 3, 2000
Transthyretin Ile84Thr is associated with familial amyloid polyneuropathyD R Booth, A Stangou, R S Williams, et al.
BMJ Open|January 24, 2015
The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling studyM Guzman-Castillo, R Ahmed, N Hawkins, et al.
The American Journal of Cardiology|November 14, 1997
Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearanceG J Clesham, D M Vigushin, P N Hawkins, et al.
Clinical Cardiology|October 4, 2000
Tissue Doppler features of cardiac amyloidosisP M Elliott, N G Mahon, Y Matsumura, et al.
Biochemical and Biophysical Research Communications|June 15, 1994
Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's diseaseP N Hawkins, M N Rossor, J R Gallimore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 10, 2004
Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish familiesElizabeth B Haagsma, Philip N Hawkins, Merrill D Benson, et al.
Pageof 58